Alyeska Investment Group
ARVN icon

Alyeska Investment Group’s Arvinas ARVN Stock Holding History

Alyeska Investment Group’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,800,000
Closed -$12.6M – 559
2025
Q1 		$12.6M Buy
+1,800,000
New +$28.2M 0.05% 291
2022
Q2 		– Sell
-143,525
Closed -$9.66M – 567
2022
Q1 		$9.66M Buy
143,525
+7,194
+5% +$490K 0.11% 213
2021
Q4 		$11.2M Buy
136,331
+86,331
+173% +$7.03M 0.13% 180
2021
Q3 		$4.11M Buy
+50,000
New +$4.42M 0.05% 370
2020
Q4 		– Sell
-109,593
Closed -$2.59M – 509
2020
Q3 		$2.59M Hold
109,593
– – 0.04% 323
2020
Q2 		$3.68M Buy
+109,593
New +$4.65M 0.06% 296
2018
Q4 		– Sell
-25,000
Closed -$422K – 362
2018
Q3 		$422K Buy
+25,000
New +$412K ﹤0.01% 382

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return